文献速递膀胱癌与上尿路尿路上皮癌

膀胱癌根治性膀胱切除术前深静脉血栓发生率

Preoperative Incidence of Deep Venous Thrombosis in Patients With Bladder Cancer Undergoing Radical Cystectomy.
PubMed 文献 · Urology · 2018-03-15

本研究评估膀胱癌患者根治性膀胱切除术前亚临床下肢深静脉血栓(DVT)的发生率及术前筛查价值。2014年起对术前7天内患者行下肢双功超声筛查,筛查组65例,历史对照组78例。结果显示术前DVT发生率为13.9%,接受新辅助化疗者风险更高(35.3% vs 5.1%,P=.008)。

要点

  • 根治性膀胱切除术前亚临床DVT发生率为13.9%,应重视术前血栓筛查。
  • 新辅助化疗患者术前DVT风险显著增高(35.3% vs 5.1%,P=.008)。
  • 术前超声筛查可能为早期干预提供机会,但术后DVT降低趋势未达统计学显著。

核心结论

  • 根治性膀胱切除术前亚临床DVT发生率较高,尤其在新辅助化疗患者中。
  • 术前下肢双功超声筛查可能识别早期干预机会,以减少围术期DVT或静脉血栓栓塞相关并发症。

研究设计与样本

  • 前瞻性队列研究,2014年起对根治性膀胱切除术前7天内患者行下肢双功超声筛查。
  • 筛查组65例,历史对照组78例,回顾2012年1月至2015年12月电子病历。

主要发现

  • 术前DVT发生率为13.9%。
  • 新辅助化疗患者亚临床DVT风险增加(35.3% vs 5.1%,P=.008)。
  • 筛查组术后DVT率较历史对照组有降低趋势,但无统计学显著性。
  • 两组总体并发症发生率和严重程度相似。

临床怎么用

  • 对拟行根治性膀胱切除术的膀胱癌患者,尤其接受新辅助化疗者,可考虑术前下肢双功超声筛查DVT。
  • 筛查发现亚临床DVT可能为早期干预提供窗口,以降低围术期血栓栓塞风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the preoperative incidence of subclinical lower-extremity deep vein thrombosis (DVT), as well as to evaluate the utility of preoperative DVT screening in patients with bladder cancer before undergoing radical cystectomy. MATERIALS AND METHODS: Beginning in 2014, we prospectively instituted a policy of obtaining a screening lower-extremity duplex ultrasound on all patients within 7 days before undergoing radical cystectomy. We reviewed the electronic medical records of all patients at our institution who underwent radical cystectomy for bladder cancer from January 2012 through December 2015. The screened group (n = 65) underwent preoperative screening; the historical control group (n = 78) did not. Primary outcome was a lower-extremity duplex ultrasound positive screening. Secondary outcome measures included the development of symptomatic venous thromboembolism (VTE) postoperatively, and the rate and severity of complications. RESULTS: DVT was identified in 13.9% of patients before undergoing cystectomy. Univariate analysis demonstrated an increased risk of subclinical DVT in patients who were exposed to neoadjuvant chemotherapy (35.3% vs 5.1%, P = .008). Postoperatively, there was a nonsignificant trend of lower DVT rate in the screened group compared to historical control. Overall complication rate and severity were similar between the groups. CONCLUSION: Subclinical DVT is present in a significant number of pre-cystectomy patients, especially those exposed to neoadjuvant chemotherapy. Ultrasound screening in patients before undergoing radical cystectomy may identify opportunities for early intervention to reduce morbidity and mortality associated with perioperative DVT or venous thromboembolism in the cystectomy population.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Schomburg JL, Krishna S, Cotter KJ, et al. Preoperative Incidence of Deep Venous Thrombosis in Patients With Bladder Cancer Undergoing Radical Cystectomy. Urology. 2018. PMID: 29551621. doi:10.1016/j.urology.2018.01.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。